HCA Gives $1 Million in Aid for Ebola Response

Center for Blood Cancers

Sarah Cannon Cancer Center for Blood Cancers provide comprehensive services for patients requiring both autologous and allogeneic hematopoietic progenitor cell transplantation. These services include the collection and processing cellular therapy products, as well as the care of the adult patient undergoing high-dose chemotherapy and hematopoietic progenitor cell transplantation. The program includes an integrated medical team in clinical, collections and cell processing facilities on the TriStar Centennial Medical Center campus. TriStar Centennial, a Joint Commission accredited facility, is an HCA owned 615-bed tertiary care medical facility and is part of the HCA TriStar division and Sarah Cannon Cancer Network of Excellence.

The Sarah Cannon Cancer Center for Blood Cancers was established in December of 2006, providing autologous transplant services for the adult patient. In April of 2007 newly dedicated space for the outpatient clinic, collection facility, inpatient unit and cell processing lab was provided in contiguous buildings, accessible thru a connector walkway. The SCCBC staff have performed 144+ autologous transplants and 37+ allogeneic transplants under the direction of the Program Director, Ian W. Flinn MD, PhD. Transplant physician services are provided through Tennessee Oncology, one of the largest physician-owned oncology practices in the country with more than fifty board-certified medical oncologists, hematologists, radiation oncologists and gynecologic oncologists in over 26 clinics in the Middle Tennessee area. Transplant physician coverage is provided 7 days per week / 24 hours per day.

Tennessee Oncology and Sarah Cannon Cancer network provide a broad-based transplant referral source throughout Tennessee, southern Kentucky and northern Alabama.